Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis.
about
Inflammatory bowel disease surgery in the biologic eraAnti-Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position PaperAnti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.Strategies for the care of adults hospitalized for active ulcerative colitisManagement of acute severe ulcerative colitis.Laparoscopic surgery for ulcerative colitisEfficacy of cyclosporine combination therapy for new-onset minimal change nephrotic syndrome in adultsPredictors of ICU Admission and Outcomes 1 Year Post-Admission in Persons with IBD: A Population-based Study.Clostridium Difficile Infection in Ulcerative Colitis: Can Alteration of the Gut-associated Microbiome Contribute to Pouch Failure?Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis.Preoperative Corticosteroid Usage and Hypoalbuminemia Increase Occurrence of Short-term Postoperative Complications in Chinese Patients with Ulcerative Colitis.Perioperative Considerations in Crohn Disease and Ulcerative Colitis.The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery.Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.Perioperative complications in inflammatory bowel disease.A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease.Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis.Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease.Review article: strategies for the management of chronic unremitting ulcerative colitis.Prolonged preoperative hospital stay is a risk factor for complications after emergency colectomy for severe colitis.The positioning of colectomy in the treatment of ulcerative colitis in the era of biologic therapy.State-of-the-art surgical approaches to the treatment of medically refractory ulcerative colitis.Surgery for Crohn's disease and anti-TNF agents: the changing scenario.Surgical management of ulcerative colitis in the era of biologicals.European evidence based consensus on surgery for ulcerative colitis.Treatment of IBD: where we are and where we are going.Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis.Management of severe ulcerative colitis.Systematic Review: Sequential Rescue Therapy in Severe Ulcerative Colitis: Do the Benefits Outweigh the Risks?A think tank of the Italian Society of Colorectal Surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: ulcerative colitis.Postoperative course of laparoscopic subtotal colectomy is affected by prolonged preoperative anti-TNF therapy in patients with acute colitis complicating inflammatory bowel disease.Association of Preoperative Anti-Tumor Necrosis Factor Therapy With Adverse Postoperative Outcomes in Patients Undergoing Abdominal Surgery for Ulcerative Colitis.Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal Anastomosis.Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.Perioperative timing of infliximab and the risk of serious infection after elective hip and knee arthroplasty.Does reduced-port laparoscopic surgery for medically uncontrolled ulcerative colitis do more harm than good?Association between high visceral fat area and postoperative complications in patients with Crohn's disease following primary surgery.Role of laparoscopic surgery in the treatment of ulcerative colitis; short- and mid-term results.
P2860
Q26745627-E9A423A8-ED24-4747-B6A8-DE51842B876BQ26783978-AD6F8316-E165-4A8A-87CF-36E50128B00EQ33564081-C63FA776-404C-4E3A-99BB-928B47DCEBD2Q33596959-A21CB741-7010-4B1F-81C8-4712AB1A66B5Q34484121-853AE5CD-FE52-4DC4-90E0-17FDBA8EF771Q34508900-BB9E6F7B-713A-4DC6-BB61-31CAE1E11C97Q35100736-05FD2E2A-4669-46A3-B6FC-BAB94514748EQ35546991-0C90392D-556C-4471-A69E-A6A23F8A2E0CQ35670649-27D0C3E1-6B5B-419B-9E4D-BCA19F50ED86Q35927505-D9AD25B9-E2EC-4458-8882-1C1F60EACC0EQ36106137-FE557F96-0A71-4238-B1DB-12CC18FEAD45Q36709373-D64FE61B-908E-4012-8083-5479BD3EAA04Q36940448-F2B87B69-E7E0-485B-B58A-E3F05B330659Q37197292-DB4DF5E4-04D0-42E4-B984-7D5A6F61EB7BQ37827687-FBAC18C8-136C-4FEA-B60E-37364CD84B1BQ37889836-03627151-B185-4DEE-9FD7-D26014DA2FF7Q37983558-61CC0626-FC07-4F68-9C60-99B963DC934EQ37998988-B5E46022-98C6-4F75-A425-783A0B9E4ECFQ38098574-4F965027-6EA8-4648-9502-D1B76207B628Q38110317-9B196B2B-81CB-404C-AB58-C92D1D52B412Q38117907-D65A5941-BFEF-44D3-A9AD-17501DD99C03Q38121000-12597F52-F0CB-474B-A4DE-558C21859A20Q38134031-A7C24090-4CDB-4D5C-AAD7-56EA8ABEEB1DQ38155663-3F03D8E1-CB18-42A6-B938-674847CDD801Q38249428-9273A62D-5099-4A35-9D95-856344C3EE36Q38258954-9A7D0158-FB86-4FAD-87C0-7E1BD628BC9FQ38285619-1641FC67-F008-4990-8035-84174A20684DQ38291763-83CF24C3-C6EB-42DC-BBE3-CDD84FCBAFE3Q38321528-CDAD3F1B-247C-41DA-AAA1-045A6477E489Q38404037-9382092D-D37B-41EE-9F84-90DE5491DF27Q38589686-E9B0AD97-F19B-40B6-8416-585E119016D2Q38691879-F8CE6DB1-3BF7-4CCE-8FCD-C9E59F2AFEEBQ38725724-F9C07008-A494-41CD-86A0-92CBD9498927Q39410539-8912008B-DFE3-4224-964E-B2B4607A1120Q40046590-FFC412C9-6DA7-46B6-B60F-3AAA8310BC5AQ40072921-68F4CF0B-90B7-414E-BF39-A2AD9D1A1DADQ40355795-223AC832-1877-48BB-B1F4-91D4DA82DE35Q40404527-571A6BAF-35A5-4299-860A-602874AC0F8EQ41337442-46082160-AB3D-4137-BEB2-B5E766DB8BB6Q41525245-2AE1D4EB-A2DE-4E49-BD46-F97A86A67B53
P2860
Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Corticosteroids but not inflix ...... ients with ulcerative colitis.
@en
Corticosteroids but not inflix ...... ients with ulcerative colitis.
@nl
type
label
Corticosteroids but not inflix ...... ients with ulcerative colitis.
@en
Corticosteroids but not inflix ...... ients with ulcerative colitis.
@nl
prefLabel
Corticosteroids but not inflix ...... ients with ulcerative colitis.
@en
Corticosteroids but not inflix ...... ients with ulcerative colitis.
@nl
P2093
P2860
P356
P1476
Corticosteroids but not inflix ...... ients with ulcerative colitis.
@en
P2093
F Penninckx
G Van Assche
M Ferrante
P Rutgeerts
S Declerck
P2860
P304
P356
10.1002/IBD.20863
P577
2009-07-01T00:00:00Z